Staff Writer

The American Society for Radiation Oncology (ASTRO) has added a Radiation Therapy for Bone Metastases section to its patient Website.

Creating art can be therapeutic. Since 2004, Lilly Oncology has held its Oncology on Canvas Art Competition and Exhibition, with more than 3000 individuals sharing their cancer experiences in art and narrative.

An Ipsos Reid study, conducted for Canada.com, surveyed 24,000 adults from 23 countries and found that individuals from Germany, Italy, Hungary, Canada, Britain, the United States, Poland, France, Belgium, and Holland were least likely to believe a cancer cure is within reach.

The explosive growth of mainstream social networking sites has encouraged the development of smaller, niche networks designed to connect patients who share a diagnosis; however, no one platform has established itself as a central health-networking hub.

The FDA has added text messaging to the ranks of e-mail digests, RSS feeds, podcasts, and Websites that comprise MedWatch, the agency's safety information and adverse event reporting program.

The Life Beyond Cancer Foundation, formerly known as the US Oncology Foundation, has launched its new Website.

Enacted in 1986, the Electronic Communications Privacy Act (ECPA) was designed to protect the electronic documents of private citizens from undue interference by law enforcement officials.

Provenge, an immunotherapy for patients with advanced prostate cancer, has become the first therapeutic vaccine for cancer ever approved by the FDA.

The FDA has added text messaging to the ranks of e-mail digests, RSS feeds, podcasts, and Websites that comprise MedWatch, the agency's safety information and adverse event reporting program.

The new site touts an array of resources or patients with cancer throughout the United States, including the latest news in cancer care and financial assistance and support programs.

Provenge, an immunotherapy for patients with advanced prostate cancer, has become the first therapeutic vaccine for cancer ever approved by the FDA.

Clinical trials are an important step to finding safer and more effective treatments for cancer and ways to detect cancer earlier. Less than 5% of patients with cancer take part in a clinical trial

Getting patients to stop smoking is rarely easy; even patients with smoking-related lung cancer occasionally continue to smoke. In addition to smoking's cancer-causing properties, it has other serious health effects for patients.

Technology plays a crucial role in patient care, not only in improving diagnostics and treatments, but by allowing practices to stay organized and efficient, which can affect the quality of patient care that is delivered.

Cancer treatment presents a major financial burden to patients and their families. Whether patients have private health insurance, government insurance, or no insurance, medical and nonmedical costs quickly consume personal and family budgets.

Interview about the IsoFlow infusion catheter

Three hot gadgets for Oncologists

Three hot gadgets for Oncologists

June-December Calender

In the United States, more than 200,000 women receive a breast cancer diagnosis annually. Early detection offers patients the best chance for a cure, but may also lead to treatment dilemmas in some patients.

Notable sessions and events

Three hot Gadgets

Proton therapy centers are being built around the country, and one of the companies leading this effort is ProCure, a company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. Since 2005, ProCure has developed several centers and more are underway.

Tarceva (erlotinib) becomes the latest drug approved by the FDA for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after 4 cycles of first-line chemotherapy with a platinum-based regimen.

An improved mammography system currently in clinical trials at Emory University�s Breast Imaging Center in Atlanta is showing dramatic improvements in both early detection of suspicious lesions and reductions in false-positive readings.

Chemotherapy errors have been attributed to many causes, including illegible handwriting, transcription errors, and human error.